Novo Nordisk to build $100m purification plant in Denmark
The company said that the new purification facility will expand its capacity to produce active pharmaceutical ingredients (APIs) for a growing number of diabetes drugs under development. The
The company said that the new purification facility will expand its capacity to produce active pharmaceutical ingredients (APIs) for a growing number of diabetes drugs under development. The
According to the company, the milestone is the first functional micro-pump integration using MEMS standard process on Leti’s 200mm line. It is a result of FluMin3, which is
MD Anderson’s Moon Shots Program would help in reducing cancer deaths by targeting eight cancers with the support of several new research platforms that provide infrastructure, expertise and
ATAGI has recommended Bexsero (meningococcal group B vaccine [rDNA, component, adsorbed]) for all young Australians, with an emphasis on infants and children under two years of age and
As part of the deal, Tesaro will receive rights to monospecific antibody drug candidates targeting TIM-3, LAG-3 and PD-1 and dual reactive antibody drug candidates targeting PD-1/TIM-3 and
SmartFactory is a single-use cGMP bio-manufacturing capacity, which will help Alvotech to rapidly expand its biosimilars business. Finesse’s customers will also have access to Alvogen’s commercial, FDA approved,
The trial will assess the clinical effects of riociguat in patients with pulmonary arterial hypertension (PAH) who show an insufficient response to treatment with phosphodiesterase-5 inhibitors (PDE-5i) either
The deal will see MedImmune contribute both funding and a post-doctoral scientist to work within the laboratory of Professor Kevin Brindle at the University of Cambridge in the
The product is a component of the contingent rights the company received in connection with its acquisition of a portfolio of ophthalmic products from Fera Pharmaceuticals and its
The company is exclusively manufacturing the approved hemophilia A therapy drug Kogenate FS/Kogenate Bayer at its Berkeley facility in California. According to Bayer, establishing an additional supply source